(4-((3-fluorobenzyl)oxy)phenyl)methanamine | 849805-95-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (4-((3-fluorobenzyl)oxy)phenyl)methanamine
• 英文别名: 1-{4-[(3-Fluorobenzyl)oxy]phenyl}methanamine；[4-[(3-fluorophenyl)methoxy]phenyl]methanamine
• CAS: 849805-95-4
• 化学式: C₁₄H₁₄FNO
• mdl: MFCD09044679
• 分子量: 231.27
• InChiKey: DLQRSGVKMVGZLB-UHFFFAOYSA-N

物化性质

• 熔点：
  44-45 °C
• 沸点：
  356.0±27.0 °C(Predicted)
• 密度：
  1.166±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (4-((3-fluorobenzyl)oxy)phenyl)methanamine 在 盐酸 作用下， 以 1,4-二氧六环 、 二氯甲烷 为溶剂， 反应 0.5h， 以1.82 g的产率得到沙芬酰胺杂质W
  参考文献：
  名称：

  Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity

  摘要：

  Several antiepileptic drugs exert their activities by inhibiting Na+ currents. Recent studies demonstrated that compounds containing a biaryl-linked motif (Ar-X-Ar') modulate Na+ currents. We, and others, have reported that compounds with an embedded benzyloxyphenyl unit (ArOCH2Ar', OCH2 = X) exhibit potent anticonvulsant activities. Here, we show that benzyloxybenzylammonium chlorides (+H3NCH2C6H4OCH2 Ar' Cl-) displayed notable activities in animal seizure models. Electrophysiological studies of 4-(2'-trifluoromethoxybenzyloxy)benzylammonium chloride (9) using embryonic cortical neurons demonstrated that 9 promoted both fast and slow inactivation of Na+ channels. These findings suggest that the potent anticonvulsant activities of the earlier compounds were due, in part, to the benzyloxyphenyl motif and provide support for the use of the biaryl-linked pharmacophore in future drug design efforts. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2013.10.031
• 作为产物：
  描述：

  3-氟溴苄 在 lithium aluminium tetrahydride 、 sodium carbonate 作用下， 以 四氢呋喃 、 丙酮 为溶剂， 反应 32.0h， 生成 (4-((3-fluorobenzyl)oxy)phenyl)methanamine
  参考文献：
  名称：

  Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity

  摘要：

  Several antiepileptic drugs exert their activities by inhibiting Na+ currents. Recent studies demonstrated that compounds containing a biaryl-linked motif (Ar-X-Ar') modulate Na+ currents. We, and others, have reported that compounds with an embedded benzyloxyphenyl unit (ArOCH2Ar', OCH2 = X) exhibit potent anticonvulsant activities. Here, we show that benzyloxybenzylammonium chlorides (+H3NCH2C6H4OCH2 Ar' Cl-) displayed notable activities in animal seizure models. Electrophysiological studies of 4-(2'-trifluoromethoxybenzyloxy)benzylammonium chloride (9) using embryonic cortical neurons demonstrated that 9 promoted both fast and slow inactivation of Na+ channels. These findings suggest that the potent anticonvulsant activities of the earlier compounds were due, in part, to the benzyloxyphenyl motif and provide support for the use of the biaryl-linked pharmacophore in future drug design efforts. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2013.10.031

文献信息

• [EN] N-ACYLAMINOBENZENE DERVATIVES AS SELECTIVE MONOAMINE OXIDASE B INHIBITORS<br/>[FR] DERIVES DE N-ACYLAMINOBENZENE COMME INHIBITEURS DE LA MONOAMINE OXYDASE B SELECTIFS
  申请人：HOFFMANN LA ROCHE

  公开号：WO2003099763A1

  公开（公告）日：2003-12-04

  This invention relates to N-acylamino aryl derivatives of the general formula (I), wherein R1 is halogen, halogen-(C1-C6)-alkyl, cyano, C1-C6-alkoxy or halogen-(C1-C6)-alkoxy; R21, R22, R23 and R24 independently from each other are selected from the group consisting of hydrogen, (C1-C6)-alkyl, halogen, halogen-(C1-C6)-alkyl, hydroxy, C1-C6-alkoxy or -CHO; R3 is hydrogen or C1-C3-alkyl; R4, R5 independently from each other are selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-alkoxy or -COO(C1-C6)alkyl; or R4 and R5 form together with the C-atom to which they are attach a C3-C7-cycloalkyl ring; R6 is -CO-NR7R8; -COO(C1-C6)-alkyl, -CN, -NR2 or -NHC(O)R; R7 and R8 independently from each other are selected from the group consisting of hydrogen, C1-C6-alkyl, NH2 or hydroxy; R is hydrogen or C1-C6-alkyl; n is 0, 1, 2 or 3. X is -CHRO, -OCHR, -CH2S-, -SCH2-, -CH2CH2-, -CH=CH- or -C≡C-; and to pharmaceutically active acid addition salts thereof. It has been found that the compounds of general formula (I) are selective monoamine oxidase B inhibitors and they are therefore useful in the treatment of diseases mediated by monoamine oxidase B inhibitors, for example for the treatment of Alzheimer’s disease or senile dementia.

  这项发明涉及一般式(I)的N-酰氨基芳基衍生物，其中R1是卤素，卤代-(C1-C6)-烷基，氰基，C1-C6-烷氧基或卤代-(C1-C6)-烷氧基；R21、R22、R23和R24彼此独立地选自氢，(C1-C6)-烷基，卤素，卤代-(C1-C6)-烷基，羟基，C1-C6-烷氧基或-CHO的群；R3是氢或C1-C3-烷基；R4、R5彼此独立地选自氢，C1-C6-烷基，C1-C6-烷氧基或-COO(C1-C6)烷基的群；或R4和R5与它们连接的C原子一起形成一个C3-C7-环烷基环；R6是-CO-NR7R8；-COO(C1-C6)-烷基，-CN，-NR2或-NHC(O)R；R7和R8彼此独立地选自氢，C1-C6-烷基，NH2或羟基；R是氢或C1-C6-烷基；n为0、1、2或3。X是-CHRO，-OCHR，-CH2S-，-SCH2-，-CH2CH2-，-CH=CH-或-C≡C-；以及其药用活性酸盐。已发现一般式(I)的化合物是选择性单胺氧化酶B抑制剂，因此它们在治疗由单胺氧化酶B抑制剂介导的疾病中很有用，例如用于治疗阿尔茨海默病或老年性痴呆症。
• N-acylamino benzyl ether derivatives
  申请人：——

  公开号：US20030232883A1

  公开（公告）日：2003-12-18

  This invention relates to N-acylamino aryl derivatives of the formula 1 where R 1 , R 21 , R 22 , R 23 , R 3 , R 4 , R 5 R 6 , R 7 , R 8 , R, and n are as defined herein and where X is —CHRO, —OCHR—, —CH 2 S—, —SCH 2 —, —CH 2 CH 2 —, —CH═CH— or —C≡C—. The compounds of the invention are selective monoamine oxidase B inhibitors, and they are therefore useful in the treatment of diseases mediated by monoamine oxidase B, for example, for the treatment of Alzheimer's disease or senile dementia.

  这项发明涉及公式1的N-酰氨基芳基衍生物，其中R1、R21、R22、R23、R3、R4、R5、R6、R7、R8、R和n如本文所定义，且X为—CHRO、—OCHR—、—CH2S—、—SCH2—、—CH2CH2—、—CH═CH—或—C≡C—。该发明的化合物是选择性的单胺氧化酶B抑制剂，因此它们在治疗由单胺氧化酶B介导的疾病中具有用途，例如用于治疗阿尔茨海默病或老年性痴呆症。
• Novel antifungal agent containing heterocyclic compound
  申请人：Nakamoto Kazutaka

  公开号：US20070105943A1

  公开（公告）日：2007-05-10

  The present invention provides an antifungal agent represented by the formula: [wherein A 1 represents a 3-pyridyl group which may have a substituent, a quinolyl group which may have a substituent, or the like; X 1 represents a group represented by the formula —NH—C(═O)—, a group represented by the formula —C(═O)—NH—, or the like; E represents a furyl group, a thienyl group, a pyrrolyl group, a phenyl group, a pyridyl group, a tetrazolyl group, a thiazolyl group or a pyrazolyl group; with the proviso that A 1 may have 1 to 3 substituents, and E has one or two substituents].

  本发明提供了一种抗真菌剂，其表示为以下式子： [其中A1表示一个3-吡啶基团，可能具有取代基，喹啉基团，可能具有取代基或类似物；X1表示由公式—NH—C（═O）—，由公式—C（═O）—NH—或类似物表示的基团；E表示呋喃基团，噻吩基团，吡咯基团，苯基团，吡啶基团，四唑基团，噻唑基团或吡唑基团；但A1可能具有1到3个取代基，E具有一个或两个取代基。]
• Novel Antimalarial Agent Containing Heterocyclic Compound
  申请人：Nakamoto Kazutaka

  公开号：US20090227799A1

  公开（公告）日：2009-09-10

  Disclosed is an antimalarial agent containing a compound represented by the formula: [wherein A 1 represents a 3-pyridyl group that may have a substituent, a 6-quinolyl group that may have a substituent, or the like; X 1 represents a group represented by the formula —C(═O)—NH— or the like; E represents a furyl group, a thienyl group or a phenyl group; with the proviso that A 1 may have one to three substituents, and E has one of two substituents] or a salt thereof or hydrates thereof.

  揭示了一种抗疟疾剂，其包含由下式表示的化合物： [其中A1表示一个3-吡啶基团，可以有取代基，一个6-喹啉基团，可以有取代基或类似物；X1表示一个由公式-C（═O）-NH-或类似物表示的基团；E表示一个呋喃基团，噻吩基团或苯基团；但前提是A1可以有1到3个取代基，E有两个取代基之一]或其盐或水合物。
• NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND
  申请人：NAKAMOTO Kazutaka

  公开号：US20110195999A1

  公开（公告）日：2011-08-11

  The present invention provides an antifungal agent represented by the formula: wherein A 1 represents a 3-pyridyl group which may have a substituent, a quinolyl group which may have a substituent, or the like; X 1 represents a group represented by the formula —NH—C(═O)—, a group represented by the formula —C(═O)—NH—, or the like; E represents a furyl group, a thienyl group, a pyrrolyl group, a phenyl group, a pyridyl group, a tetrazolyl group, a thiazolyl group or a pyrazolyl group; with the proviso that A 1 may have 1 to 3 substituents, and E has one or two substituents.

  本发明提供一种抗真菌剂，其化学式如下： 其中，A1代表3-吡啶基，可以有取代基，喹啉基，也可以有取代基等；X1代表由公式—NH—C（═O）—，由公式—C（═O）—NH—等表示的基团；E代表呋喃基，噻吩基，吡咯基，苯基，吡啶基，四唑基，噻唑基或吡唑基；但要求A1可能有1到3个取代基，E有1或2个取代基。